Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+


  Breast Cancer

  Free Subscription


11.11.2019

3 AJR Am J Roentgenol
2 Ann Surg Oncol
7 BMC Cancer
2 Br J Cancer
2 Breast Cancer
1 Breast Cancer Res
2 Breast Cancer Res Treat
1 Cancer
1 Cancer Epidemiol Biomarkers Prev
1 Cancer Res
2 Eur J Surg Oncol
1 Eur Radiol
1 Int J Cancer
4 Int J Radiat Oncol Biol Phys
2 J Natl Cancer Inst
1 J Nucl Med
1 Oncogene
4 PLoS One
1 Proc Natl Acad Sci U S A


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    AJR Am J Roentgenol

  1. GAO Y, Geras KJ, Lewin AA, Moy L, et al
    New Frontiers: An Update on Computer-Aided Diagnosis for Breast Imaging in the Age of Artificial Intelligence.
    AJR Am J Roentgenol. 2019;212:300-307.
    PubMed     Text format     Abstract available

  2. CODARI M, Schiaffino S, Sardanelli F, Trimboli RM, et al
    Artificial Intelligence for Breast MRI in 2008-2018: A Systematic Mapping Review.
    AJR Am J Roentgenol. 2019 Jan 2:1-13. doi: 10.2214/AJR.18.20389.
    PubMed     Text format     Abstract available

  3. LEE CS, Sickles EA, Moy L
    Risk Stratification for Screening Mammography: Benefits and Harms.
    AJR Am J Roentgenol. 2018 Dec 17:1-9. doi: 10.2214/AJR.18.20345.
    PubMed     Text format     Abstract available


    Ann Surg Oncol

  4. POMPONIO M, Keele L, Hilt E, Burkbauer L, et al
    Impact of 21-Gene Expression Assay on Clinical Outcomes in Node-Negative </= T1b Breast Cancer.
    Ann Surg Oncol. 2019 Nov 4. pii: 10.1245/s10434-019-08028.
    PubMed     Text format     Abstract available

  5. CONLEY CC, Kasting ML, Augusto BM, Garcia JD, et al
    Impact of Genetic Testing on Risk-Management Behavior of Black Breast Cancer Survivors: A Longitudinal, Observational Study.
    Ann Surg Oncol. 2019 Nov 1. pii: 10.1245/s10434-019-07982.
    PubMed     Text format     Abstract available


    BMC Cancer

  6. ZHAO CL, Singh K, Brodsky AS, Lu S, et al
    Stromal ColXalpha1 expression correlates with tumor-infiltrating lymphocytes and predicts adjuvant therapy outcome in ER-positive/HER2-positive breast cancer.
    BMC Cancer. 2019;19:1036.
    PubMed     Text format     Abstract available

  7. BOLANDGHAMAT POUR Z, Nourbakhsh M, Mousavizadeh K, Madjd Z, et al
    Suppression of nicotinamide phosphoribosyltransferase expression by miR-154 reduces the viability of breast cancer cells and increases their susceptibility to doxorubicin.
    BMC Cancer. 2019;19:1027.
    PubMed     Text format     Abstract available

  8. BAZAN F, Dobi E, Royer B, Curtit E, et al
    Systemic high-dose intravenous methotrexate in patients with central nervous system metastatic breast cancer.
    BMC Cancer. 2019;19:1029.
    PubMed     Text format     Abstract available

  9. HILL DP, Harper A, Malcolm J, McAndrews MS, et al
    Cisplatin-resistant triple-negative breast cancer subtypes: multiple mechanisms of resistance.
    BMC Cancer. 2019;19:1039.
    PubMed     Text format     Abstract available

  10. DE AMICIS F, Chiodo C, Morelli C, Casaburi I, et al
    AIB1 sequestration by androgen receptor inhibits estrogen-dependent cyclin D1 expression in breast cancer cells.
    BMC Cancer. 2019;19:1038.
    PubMed     Text format     Abstract available

  11. ZHU C, Menyhart O, Gyorffy B, He X, et al
    The prognostic association of SPAG5 gene expression in breast cancer patients with systematic therapy.
    BMC Cancer. 2019;19:1046.
    PubMed     Text format     Abstract available

  12. SUROV A, Chang YW, Li L, Martincich L, et al
    Apparent diffusion coefficient cannot predict molecular subtype and lymph node metastases in invasive breast cancer: a multicenter analysis.
    BMC Cancer. 2019;19:1043.
    PubMed     Text format     Abstract available


    Br J Cancer

  13. SIM SH, Park IH, Jung KH, Kim SB, et al
    Randomised Phase 2 study of lapatinib and vinorelbine vs vinorelbine in patients with HER2 + metastatic breast cancer after lapatinib and trastuzumab treatment (KCSG BR11-16).
    Br J Cancer. 2019 Nov 6. pii: 10.1038/s41416-019-0618.
    PubMed     Text format     Abstract available

  14. XUE Y, Lian W, Zhi J, Yang W, et al
    HDAC5-mediated deacetylation and nuclear localisation of SOX9 is critical for tamoxifen resistance in breast cancer.
    Br J Cancer. 2019 Nov 6. pii: 10.1038/s41416-019-0625.
    PubMed     Text format     Abstract available


    Breast Cancer

  15. WANG X, Luo J, Jin K, Chen X, et al
    Internal mammary node irradiation improves 8-year survival in breast cancer patients: results from a retrospective cohort study in real-world setting.
    Breast Cancer. 2019 Nov 6. pii: 10.1007/s12282-019-01015.
    PubMed     Text format     Abstract available

  16. AKEZAKI Y, Nakata E, Kikuuchi M, Tominaga R, et al
    Risk factors for early postoperative psychological problems in breast cancer patients after axillary lymph node dissection.
    Breast Cancer. 2019 Nov 2. pii: 10.1007/s12282-019-01020.
    PubMed     Text format     Abstract available


    Breast Cancer Res

  17. JUNG AY, Behrens S, Schmidt M, Thoene K, et al
    Pre- to postdiagnosis leisure-time physical activity and prognosis in postmenopausal breast cancer survivors.
    Breast Cancer Res. 2019;21:117.
    PubMed     Text format     Abstract available


    Breast Cancer Res Treat

  18. CAO S, Wei F, Zhou J, Zhu Z, et al
    The synergistic effect between adult weight changes and CYP24A1 polymorphisms is associated with pre- and postmenopausal breast cancer risk.
    Breast Cancer Res Treat. 2019 Nov 6. pii: 10.1007/s10549-019-05484.
    PubMed     Text format     Abstract available

  19. KARIRI YA, Joseph C, Kurozumi S, Toss MS, et al
    Prognostic significance of KN motif and ankyrin repeat domains 1 (KANK1) in invasive breast cancer.
    Breast Cancer Res Treat. 2019 Nov 2. pii: 10.1007/s10549-019-05466.
    PubMed     Text format     Abstract available


    Cancer

  20. WINN AN, Dusetzina SB
    More evidence on the limited impact of state oral oncology parity laws.
    Cancer. 2019;125:335-336.
    PubMed     Text format    


    Cancer Epidemiol Biomarkers Prev

  21. GEORGE A, Sturgeon SR, Hankinson SE, Shadyab AH, et al
    Psychotropic medication use and postmenopausal breast cancer risk.
    Cancer Epidemiol Biomarkers Prev. 2019 Nov 4. pii: 1055-9965.EPI-19-0776.
    PubMed     Text format     Abstract available


    Cancer Res

  22. UMEH-GARCIA M, Simion C, Ho PY, Batra N, et al
    A Novel Bioengineered MicroRNA-127 Prodrug Suppresses The Growth And Metastatic Potential Of Triple Negative Breast Cancer Cells.
    Cancer Res. 2019 Nov 6. pii: 0008-5472.CAN-19-0656.
    PubMed     Text format     Abstract available


    Eur J Surg Oncol

  23. FRANCESCHINI G
    Sentinel node biopsy after neoadjuvant chemotherapy for breast cancer in patients with pre-treatment node-positive: Recommendations to optimize the performance.
    Eur J Surg Oncol. 2019 Oct 24. pii: S0748-7983(19)30900.
    PubMed     Text format    

  24. LUCIDI V, Bohlok A, Liberale G, Bez M, et al
    Extended time interval between diagnosis and surgery does not improve the outcome in patients operated for resection or ablation of breast cancer liver metastases.
    Eur J Surg Oncol. 2019 Oct 12. pii: S0748-7983(19)30896.
    PubMed     Text format     Abstract available


    Eur Radiol

  25. BAE SJ, Youk JH, Yoon CI, Park S, et al
    A nomogram constructed using intraoperative ex vivo shear-wave elastography precisely predicts metastasis of sentinel lymph nodes in breast cancer.
    Eur Radiol. 2019 Nov 6. pii: 10.1007/s00330-019-06473.
    PubMed     Text format     Abstract available


    Int J Cancer

  26. BRANDAO RD, Mensaert K, Lopez-Perolio I, Tserpelis D, et al
    Targeted RNA-seq successfully identifies normal and pathogenic splicing events in breast/ovarian cancer susceptibility and Lynch syndrome genes.
    Int J Cancer. 2019 Jan 8. doi: 10.1002/ijc.32114.
    PubMed     Text format     Abstract available


    Int J Radiat Oncol Biol Phys

  27. KHAN AJ, Chen PY, Yashar C, Poppe MM, et al
    Three-Fraction Accelerated Partial Breast Irradiation (APBI) Delivered With Brachytherapy Applicators Is Feasible and Safe: First Results From the TRIUMPH-T Trial.
    Int J Radiat Oncol Biol Phys. 2019;104:67-74.
    PubMed     Text format     Abstract available

  28. PATEL V, James M, Frampton C, Robinson B, et al
    Body mass index and outcomes in breast cancer treated with breast conservation.
    Int J Radiat Oncol Biol Phys. 2019 Oct 30. pii: S0360-3016(19)33959.
    PubMed     Text format     Abstract available

  29. FAYANJU OM, Ren Y, Suneja G, Thomas SM, et al
    Nodal Response to Neoadjuvant Chemotherapy Predicts Receipt of Radiation Therapy after Breast Cancer Diagnosis.
    Int J Radiat Oncol Biol Phys. 2019 Oct 31. pii: S0360-3016(19)33962.
    PubMed     Text format     Abstract available

  30. JETHWA KR, Park SS, Gonuguntla K, Wick SM, et al
    Three-Fraction Intracavitary Accelerated Partial Breast Brachytherapy: Early Provider and Patient-Reported Outcomes of a Novel Regimen.
    Int J Radiat Oncol Biol Phys. 2019;104:75-82.
    PubMed     Text format     Abstract available


    J Natl Cancer Inst

  31. BRUFSKY A, Mathew A
    Bisphosphonate Choice as Adjuvant Therapy for Breast Cancer: Does It Matter?
    J Natl Cancer Inst. 2019 Nov 6. pii: 5613898. doi: 10.1093.
    PubMed     Text format    

  32. GRALOW JR, Barlow WE, Paterson AHG, Miao JL, et al
    Phase III randomized trial of bisphosphonates as adjuvant therapy in breast cancer: S0307.
    J Natl Cancer Inst. 2019 Oct 31. pii: 5613900. doi: 10.1093.
    PubMed     Text format     Abstract available


    J Nucl Med

  33. MORTIMER JE, Shively JE
    Functional Imaging of Human Epidermal Growth Factor Receptor 2-Positive Breast Cancers and a Note about NOTA.
    J Nucl Med. 2019;60:23-25.
    PubMed     Text format    


    Oncogene

  34. CHENG R, Billet S, Liu C, Haldar S, et al
    Periodontal inflammation recruits distant metastatic breast cancer cells by increasing myeloid-derived suppressor cells.
    Oncogene. 2019 Nov 4. pii: 10.1038/s41388-019-1084.
    PubMed     Text format     Abstract available


    PLoS One

  35. AFKHAMI M, Schmolze D, Yost SE, Frankel PH, et al
    Mutation and immune profiling of metaplastic breast cancer: Correlation with survival.
    PLoS One. 2019;14:e0224726.
    PubMed     Text format     Abstract available

  36. CURRY JM, Besmer DM, Erick TK, Steuerwald N, et al
    Indomethacin enhances anti-tumor efficacy of a MUC1 peptide vaccine against breast cancer in MUC1 transgenic mice.
    PLoS One. 2019;14:e0224309.
    PubMed     Text format     Abstract available

  37. HUANG YH, Lee MS, Lou YS, Lai HC, et al
    Propofol-based total intravenous anesthesia did not improve survival compared to desflurane anesthesia in breast cancer surgery.
    PLoS One. 2019;14:e0224728.
    PubMed     Text format     Abstract available

  38. HEDAYATI E, Fracheboud L, Srikant V, Greber D, et al
    Economic benefits of subcutaneous trastuzumab administration: A single institutional study from Karolinska University Hospital in Sweden.
    PLoS One. 2019;14:e0211783.
    PubMed     Text format     Abstract available


    Proc Natl Acad Sci U S A

  39. RODRIGUES-FERREIRA S, Nehlig A, Moindjie H, Monchecourt C, et al
    Improving breast cancer sensitivity to paclitaxel by increasing aneuploidy.
    Proc Natl Acad Sci U S A. 2019 Nov 4. pii: 1910824116.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Breast Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: